A simple, digital intervention that includes mentally playing Tetris can dramatically reduce intrusive memories of trauma in a month, even to the point of being symptom-free after six months, new research has found.
Children and young people faced long-lasting and higher risks of rare heart and inflammatory complications after COVID-19 infection, compared to before or without an infection, according to new research. Meanwhile COVID-19 vaccination was only linked to a short-term higher risk of myocarditis and pericarditis.
The Victor Phillip Dahdaleh Heart and Lung Research Institute is a thriving community of scientists and clinicians, the largest concentration of its kind in Europe, focused on tackling the world's biggest killers.
A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, Cambridge researchers have found.
Clare Bryant, Professor of Innate Immunity, is a molecular detective. Clare allows us to see how inflammation functions across species, and when our defence systems go too far.
Medical students are taught about some of the rarest diseases, yet do not learn something as important as how to care for trans patients. This needs to change, says intensive care specialist Luke Flower.
Our risk of developing atherosclerosis – ‘furring’ of the arteries – can begin much earlier in life than was previously thought, highlighting the need to keep cholesterol levels low even when we are young, new research has discovered.
Repurposed cancer drug helps to calm inflammation in arteries.
Pseudomonas aeruginosa – an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions – evolved rapidly and then spread globally over the last 200 years, probably driven by changes in human behaviour, a new study has found.
Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look at COVID-19 vaccine coverage of the entire UK population.
© 2026 University of Cambridge